Track topics on Twitter Track topics that are important to you
Dublin, June 02, 2015 (GLOBE NEWSWIRE) -- Research and Markets (http://www.researchandmarkets.com/research/2hglmm/molecular) has announced the addition of the "Molecular Diagnostics - Global Market Size, Strategy and Forecasts - 2015 to 2019" report to their offering.
"Molecular Diagnostics - Global Market Size, Strategy and Forecasts - 2015 to 2019" provides data that analysts and planners can use. Hundreds of pages of information including a complete list of Current 2015 United States Medicare Fee Payment Schedules to help understand test pricing in detail.
See lists of all current FDA Approved Molecular Diagnostic Tests. Make facilities planning decisions. Forecast demand for new testing regimes or technologies. Make research investment decisions. Based on extensive primary and secondary research the testing volume data is broken down into price and volumes allowing researchers and investors to quickly create informed and reasonable forecasts of demand. Assistance in providing specific growth and market size estimates for new technology tests is normally provided without additional charges. Existing laboratories and hospitals can use the information directly to forecast and plan for clinical facilities growth. Again, assistance in using the information is normally provided without additional charges.
Detailed Market Forecasts provide Price, Volume and Revenue Forecasts individually broken out by year for Infectious Disease, Genetic Testing, Oncology Testing. Report Buyers have access to Price and Volume Data for the following individual tests:
Key Topics Covered:
1. Introduction and Market Definition
2. Market Overview
3. Market Trends
4. Molecular Diagnostics Recent Developments
5. Country Market Sizes - North America
6. Country Markets - Europe
7. Country Markets - Asia Pacific
8. Country Markets - Latin America, Africa & The Middle East
9. Global Market Summary
I. United States Medicare System: January 2015 Clinical Laboratory Fees Schedule - National Limit and Midpoint
II. FDA Approved Human Genetic Tests
III. FDA Approved Microbial Tests
III. FDA Approved Pharmacogenomics Tests
Companies Mentioned: 30 of the 300+ companies featured
- 14M Genomics
- 20/20 GeneSystems
- Abbott Diagnostics
- Accelerate Diagnostics
- Acibadem Labmed Laboratory
- ACM Medical Laboratory
- ACT Genomics
- Adaptive Biotechnologies
- Adarza BioSystems
- Adicon Clinical Laboratories, Inc.
- Advanced Cell Diagnostics
- Aegis Sciences
- Aeris Capital
- Aetna Innovation Lab
- Agena Bioscience
- Alberta Investment Management
- Alere Inc
- Allegro Dx
- Alliance Global
- Amarantus BioScience
- American Liberty Petroleum
- American Pathology Partners, Inc.
For more information visit http://www.researchandmarkets.com/research/2hglmm/molecular
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: Research and Markets Laura Wood, Senior Manager firstname.lastname@example.org For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716 Sector: Healthcare and Medical Devices, DiagnosticsNEXT ARTICLE
A diagnostic test is any kind of medical test performed to aid in the diagnosis or detection of disease. For example: to diagnose diseases to measure the progress or recovery from disease to confirm that a person is free from disease Clin...